Cargando…
A novel nicastrin mutation in a three‐generation Dutch family with hidradenitis suppurativa: a search for functional significance
BACKGROUND: Mutations in the γ‐secretase enzyme subunits have been described in multiple kindreds with familial hidradenitis suppurativa (HS). OBJECTIVE: In this study, we report a novel nicastrin (NCSTN) mutation causing HS in a Dutch family. We sought to explore the immunobiological function of NC...
Autores principales: | Vossen, A.R.J.V., van Straalen, K.R., Swagemakers, S.M.A., de Klein, J.E.M.M., Stubbs, A.P., Venter, D.J., van der Zee, H.H., van der Spek, P.J., Prens, E.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586943/ https://www.ncbi.nlm.nih.gov/pubmed/32078194 http://dx.doi.org/10.1111/jdv.16310 |
Ejemplares similares
-
Primary alterations during the development of hidradenitis suppurativa
por: Dajnoki, Z., et al.
Publicado: (2021) -
Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials
por: van der Zee, H.H., et al.
Publicado: (2019) -
Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers
por: Vossen, A.R.J.V., et al.
Publicado: (2018) -
Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study
por: Prens, L.M., et al.
Publicado: (2019) -
Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study
por: Gulliver, W., et al.
Publicado: (2021)